Lipid Infusions to Optimize Nutrition Trial
Recruiting
Phase 2
Interventional Study
Bronchopulmonary Dysplasia
Neurodevelopmental Impairment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 12 Hours – 28 Weeks
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 230 (estimated)
- Sponsor
- The University of Texas Health Science Center, Houston · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to identify survival free of bronchopulmonary dysplasia (BPD), fatty acid profiles, and early biochemical measures for oxidative stress comparing mixed oil lipid emulsion (MOLE) vs soybean oil-based lipid emulsion (SOLE) and to establish whether MOLE or SOLE is more effective in minimizing pulmonary outcomes, neonatal morbidities, long-term morbidity and mortality, and…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* inborn \<28 weeks gestational age (GA) or ≤1000g birth weight (BW)
* survives until 12 hours after birth.
Exclusion Criteria:
* Infants who are unable to be enrolled by 96 hours postnatal age
* Major anomaly
* Overt non-bacterial infection
* Infants likely to expire soon def…
Contacts